Popular Articles

Washington Times Opinion Piece, Editorial Discuss DOJ Nominee Johnsen
The Washington Times recently published an opinion piece and an editorial discussing President Obama"s nomination of Indiana University law professor Dawn Johnsen to head the Office of Legal Counsel in the Justice Department. Summaries appear below. ~ Mickey Edwards/William Sessions, Washington Times: The Senate should "act expeditiously to approve" Johnsen"s nomination because "her views on the limits of presidential power are precisely what the Constitution envisions and conservatives have long championed," Edwards, vice president of the Aspen Institute and author of "Reclaiming Conservatism," and Sessions, a partner at the law firm Holland & Knight, write in a Times opinion piece. According to the authors, Johnsen "made her views clear" on the limits of presidential power when she joined a bipartisan group of lawyers that declared that the Office of Legal Counsel should promote "presidential adherence to the rule of law." Edwards and Sessions write that Johnsen is being criticized for "being blunt, unserious and critical of presidential policies." However, these attacks are unwarranted, they write, noting that in the legal profession, "a little blunt talk to a client -- in this case, the president of the United States -- might be required." Edwards and Sessions continue, "What is needed in the Office of Legal Counsel is a person with the constitutional understanding to know that even presidents with whose politics she agrees must obey both the Constitution and federal statutes and who has the gumption to say so, even if the advice won"t be well received" (Edwards/Sessions, Washington Times, 5/21).~ Washington Times: The editorial states that Johnsen "is so radical" that 31 Republican Indiana state senators on Monday sent a letter to Sens. Evan Bayh (D-Ind.) and Dick Lugar (R-Ind.) asking them to oppose her confirmation. The Republican senators called Johnsen"s views supporting abortion rights "extremely radical" and said she often uses "harsh, sensationalizing rhetoric" in her writings on Supreme Court cases, the editorial states. According to the editorial, Johnsen"s "political advocacy shows a profound disregard for the courts" proper role" because she considers the courts "as making up just another political, policymaking branch of government, not as bodies restrained by the Constitution or existing laws." The editorial continues that Johnsen is "guilty" of "asking judges to impose their own policy preferences" in favor of abortion rights "against the dictates of existing constitutional law." The editorial concludes, "Someone with such contemptuous views of the Constitution should not be the Obama administration"s chief constitutional interpreter" (Washington Times, 5/21).
generic viagra
National Alliance On Mental Illness Observes Minority Mental Health Awareness Month
The National Alliance on Mental Illness (NAMI) reminds Americans that July is Bebe Moore Campbell National Minority Mental Health Awareness Month, a time for public education about serious mental illness in diverse communities.
Health Insurance

Number Of Patients With Dementia On The Rise

At 81, Alberta Sabin"s mind is not as sharp as it used to be, and she knows it. She frequently misplaces common items, forgets names and appointments, some of the most frustrating aspects of memory loss, she says. "I had been looking for my cell phone for three days and would you believe I found it laying on the counter in plain sight?," Sabin says. "There it was and I thought why didn"t I see it before?" It is that frustration that motivated Sabin to participate in U-M sponsored research designed to better diagnose and treat dementia before it escalates. Sabin is one of millions of Americans who experience memory loss and may eventually be diagnosed with dementia. "This is an explosive disease," says Sid Gilman, M.D., director of the Alzheimer"s Disease Research Center at University of Michigan Health System, who conducts research with Sabin and others in her community. "It"s a horrible disease that robs people of their humanity. They forget their families and friends." Roughly 50 percent of people who reach 85 will become demented, according to studies conducted by investigators at Rush Medical Center in Chicago. By age 100, the number spikes to 60 percent. Of those who develop dementia, roughly 60 percent will prove to have Alzheimer"s disease. It"s predicted that the current number of patients with Alzheimer"s disease in the United States is roughly 5 million. By the year 2050, it will grow to about 30 million, presenting a significant financial burden to the healthcare system. Gilman and other researchers at the Michigan Alzheimer"s Disease Research Center (MADRC), have a keen interest in patients like Sabin. The center first received grant support from the National Institutes of Health in 1989 and has continued to receive funding since. Researchers at the MADRC have so far studied 80 patients in a project that has been going on for four years on the diagnosis of Alzheimer"s at the earliest sign of cognitive dysfunction. Researchers would ultimately like to evaluate 120. One of the goals of the research is to determine the best tool for the early diagnosis of Alzheimer"s disease: PET scans or clinical evaluations. In addition to Alzheimer"s disease, there are other possible diagnoses with early onset cognitive impairment, including multiple strokes, frontotemporal dementia, corticobasal degeneration, and the cognitive disorder associated with Parkinson"s disease, which is termed dementia with Lewy bodies. "The earliest possible treatment for Alzheimer"s disease would be to the patient"s greatest advantage," Gilman says. PET, or positron emission tomography, is an imaging study that allows doctors to evaluate the use of certain substances by the brain. Normally, the brain uses glucose as a fuel. Using PET scans, doctors can image the amount of glucose used by the brain to determine whether there"s a difference in brain use by the frontal lobe, temporal lobe or the parietal lobe. PET gives the ability to make predictions as to those individuals who will go on from mild impairment of memory to developing Alzheimer"s disease. These patients may then qualify to participate in clinical trials for medications that treat Alzheimer"s. Studies with glucose are being supplemented by PET scans that can image beta-amyloid, one of the abnormal proteins in the brain in Alzheimer"s disease. Sabin, whose mother and grandmother had dementia, is participating in U-M research that will help researchers diagnose and treat the illness earlier in life. "I have trouble remembering names and the most frustrating is when they are names of people I know really well, I just can"t bring the name to the surface," Sabin says. "I felt I needed to do this because with my family history," Sabin says. "I felt studies I was participating in would help other people so that they won"t have to go through what I did with my own relatives." University of Michigan Health System


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):